Mst1 overexpression inhibited the growth of human non-small cell lung cancer in vitro and in vivo
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Mst1 overexpression inhibited the growth of human non-small cell lung cancer in vitro and in vivo
Authors
Keywords
-
Journal
CANCER GENE THERAPY
Volume 20, Issue 8, Pages 453-460
Publisher
Springer Nature
Online
2013-08-09
DOI
10.1038/cgt.2013.40
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effect of Mst1 overexpression on the growth of human hepatocellular carcinoma HepG2 cells and the sensitivity to cisplatin in vitro
- (2013) C. Xu et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- Novel therapeutic targets in non-small cell lung cancer
- (2013) Muhammad Alamgeer et al. CURRENT OPINION IN PHARMACOLOGY
- Full-length Mst1 exhibits growth promoting function in human hepatocellular carcinoma cells
- (2013) Yuen-Keng Ng et al. FEBS LETTERS
- YAP modifies cancer cell sensitivity to EGFR and survivin inhibitors and is negatively regulated by the non-receptor type protein tyrosine phosphatase 14
- (2012) J-M Huang et al. ONCOGENE
- A Novel Classification of Lung Cancer into Molecular Subtypes
- (2012) Lisandra West et al. PLoS One
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The Hippo pathway transcriptional co-activator, YAP, is an ovarian cancer oncogene
- (2011) X Zhang et al. ONCOGENE
- Mst1 and Mst2 protein kinases restrain intestinal stem cell proliferation and colonic tumorigenesis by inhibition of Yes-associated protein (Yap) overabundance
- (2011) D. Zhou et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hippo signaling: growth control and beyond
- (2010) G. Halder et al. DEVELOPMENT
- The Merlin/NF2 Tumor Suppressor Functions through the YAP Oncoprotein to Regulate Tissue Homeostasis in Mammals
- (2010) Nailing Zhang et al. DEVELOPMENTAL CELL
- Targeting YAP and Hippo signaling pathway in liver cancer
- (2010) Angela M Liu et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Mammalian Mst1 and Mst2 kinases play essential roles in organ size control and tumor suppression
- (2010) H. Song et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver
- (2010) L. Lu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cancer screening in the United States, 2009: A review of current American Cancer Society guidelines and issues in cancer screening
- (2009) R. A. Smith et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Mst1 and Mst2 Maintain Hepatocyte Quiescence and Suppress Hepatocellular Carcinoma Development through Inactivation of the Yap1 Oncogene
- (2009) Dawang Zhou et al. CANCER CELL
- Using lentiviral vectors for efficient pancreatic cancer gene therapy
- (2009) E Ravet et al. CANCER GENE THERAPY
- Crucial Role for Mst1 and Mst2 Kinases in Early Embryonic Development of the Mouse
- (2009) S. Oh et al. MOLECULAR AND CELLULAR BIOLOGY
- YAP-dependent induction of amphiregulin identifies a non-cell-autonomous component of the Hippo pathway
- (2009) Jianmin Zhang et al. NATURE CELL BIOLOGY
- Biosignaling of mammalian Ste20-related kinases
- (2008) Pin Ling et al. CELLULAR SIGNALLING
- TEAD mediates YAP-dependent gene induction and growth control
- (2008) B. Zhao et al. GENES & DEVELOPMENT
- Expression of Yes-associated protein in common solid tumors
- (2008) Angela A. Steinhardt et al. HUMAN PATHOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now